The FTSE 100 has ended the session up 3.1 points, or 0.05%, to 6,416.4, as positive trading news offset losses by property companies.
SABMiller posted the biggest gains with a rise of 2.59% to £11.48, closely followed by British Airways which added 2.09% to 514p, while Morrison Supermarkets climbed 1.7% to 314.5p.
Drug companies also performed well with GlaxoSmithKline up 1.49% to £14.33, while AstraZeneca advanced 1.14% to £27.51, although gains were limited by Scottish & Newcastle which fell 2.09% to 586p, while ICAP dropped 1.82% to 525.75p.
Property companies dropped following a report on the US housing market, with Slough Estates posting the biggest losses with a fall of 2.38% to 778p, while Land Securities Group slipped 1.97% to £21.35, and International Power declined 1.97% to 410p.
In the US the Dow Jones Industrial Average is up 6.66 points, or 0.05%, to 12,491.28 in early trading, despite a surprise increase in weekly jobless claims.
Drug companies are posting the biggest gains with Pfizer up 1.46% to $26.42, closely followed by Merck which has added 0.66% to $45.95, while Du Pont has advanced 0.68% to $48.99.
Honeywell International is also up 1.12% to $46.91, while Microsoft has added 0.96% to $28.39, although gains are being limited by Verizon Communications which has slipped 0.64% to $37.14.
AT&T is the biggest loser with a drop of 0.77% to $38.64, closely followed by Alcoa which has fallen 0.57% to $34.88, while Intel has dropped 0.39% to $20.39, and JP Morgan Chase has declined 0.33% to $48.99.
If you have any comments you would like to add to this story or would like to speak to its author about a similar subject, telephone Nyree Stewart on 020 7034 2681 or email [email protected]IFAonline
The forces at play in investment - most obviously, regulatory change, uncertain markets and shifting demographics - are as strong today as they were when Professional Adviser launched its sister magazine Multi-Asset Review in 2017.
Regulator has visited some firms already
Platforms react to Fidelity blocking Income Focus purchases
Chris Hill's letter to Treasury
Cash balance surges